Investor Relations

ResMed (NYSE: RMD and ASX: RMD.AX) is a leading developer, manufacturer and marketer of products for the screening, treatment and long-term management of sleep-disordered breathing (SDB) and other respiratory disorders. ResMed operates in over 68 countries via 18 direct o... More >>

ResMed to Webcast Fourth Quarter and Fiscal Year End Earnings Conference Call - 07/22/08

SAN DIEGO, July 22 /PRNewswire-FirstCall/ -- RESMED INC. (NYSE: RMD), announced today that on Tuesday, August 5, 2008, it will release its fourth quarter and fiscal year end earnings for the period ended June 30, 2008. ResMed will issue an ear... More >>

ResMed Inc Announces Financial Results for the Quarter and Nine Months Ended March 31, 2008 - 05/01/08

SAN DIEGO, May 1 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) today announced revenue and income results for the quarter ended March 31, 2008. Revenue for the quarter was $211.8 million, a 16% increase over the quarter ended March 31, 200... More >>

ResMed to Webcast Third Quarter 2008 Earnings Conference Call - 04/17/08

SAN DIEGO, April 17 /PRNewswire-FirstCall/ -- RESMED INC. (NYSE: RMD), announced today that on Thursday, May 1, 2008, it will release its earnings for the third quarter of fiscal year 2008, ended March 31, 2008. ResMed will issue an earnings ... More >>

ResMed Inc Announces Financial Results for the Quarter and Six Months Ended December 31, 2007 - 02/07/08

SAN DIEGO, Feb. 7 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) today announced revenue and income results for the quarter ended December 31, 2007. Revenue for the quarter was $202.7 million, a 14% increase over the quarter ended December ... More >>

RESMED to Webcast Second Quarter 2008 Earnings Conference Call - 01/24/08

SAN DIEGO, Jan. 24 /PRNewswire-FirstCall/ -- RESMED INC. (NYSE: RMD), announced today that on Thursday, February 7, 2008, it will release its earnings for this second quarter of fiscal year 2008, ended December 31, 2007. ResMed will issue an e... More >>

Kieran Gallahue Appointed Chief Executive Officer of ResMed. - 01/02/08

Dr. Peter Farrell becomes Executive Chairman of the Board SAN DIEGO, Jan. 2 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) announced today that effective January 1, 2008, its board of directors has appointed Kieran T. Gallahue to ... More >>

ResMed Announces Financial Results for Quarter Ended September 30, 2007 - 11/01/07

SAN DIEGO, Nov. 1 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) today announced revenue and income results for the quarter ended September 30, 2007. Revenue for the quarter was $185.7 million, a 14% increase over the quarter ended Septembe... More >>

ResMed to Webcast First Quarter 2008 Earnings Conference Call - 10/19/07

SAN DIEGO, Oct. 19 /PRNewswire-FirstCall/ -- RESMED INC. (NYSE: RMD), announced today that on Thursday, November 1, 2007, it will release its earnings for this first quarter of fiscal year 2008, ended September 30, 2007. ResMed will issue an e... More >>

ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008. - 08/30/07

Dr. Peter Farrell to remain Chairman of the Board SAN DIEGO, Aug. 30 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) announced today that its board of directors has unanimously approved a succession plan for executive managemen... More >>

ResMed Inc. Announces Financial Results for Quarter and Year Ended June 30, 2007 - 08/07/07

SAN DIEGO, Aug. 7 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) today announced revenue and pro forma income results for the quarter ended June 30, 2007. Revenue for the quarter was $191.3 million, a 12% increase over the quarter ended Ju... More >>